T2 Biosystems Inc. [NASDAQ: TTOO] gained 13.24% or 0.29 points to close at $2.48 with a heavy trading volume of 7496352 shares. The company report on February 23, 2021 that T2 Biosystems to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021.
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced that it will report financial results for the fourth quarter and full year 2020 after market close on Thursday, March 4, 2021. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. The call will also be available by dialing 877-407-9208 (U.S.) or 201-493-6784 (International) five to ten minutes prior to the start time.
It opened the trading session at $2.267, the shares rose to $2.64 and dropped to $2.26, the range by which the price of stock traded the whole day. The daily chart for TTOO points out that the company has recorded 60.00% gains over the past six months. However, it is still -978.26% lower than its most recent low trading price.
If we look at the average trading volume of 11.95M shares, TTOO reached to a volume of 7496352 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about T2 Biosystems Inc. [TTOO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TTOO shares is $3.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TTOO stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.38, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 28.35. The Price to Book ratio for the last quarter was 20.67, with the Price to Cash per share for the same quarter was set at 0.27.
Trading performance analysis for TTOO stock
T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.77. With this latest performance, TTOO shares gained by 17.54% in over the last four-week period, additionally plugging by 60.00% over the last 6 months – not to mention a rise of 241.08% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 48.97, with the RSI for the last a single of trading hit 44.03, and the three-weeks RSI is set at 51.91 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 1.98, while it was recorded at 2.59 for the last single week of trading, and 1.48 for the last 200 days.
T2 Biosystems Inc. [TTOO]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -624.57 and a Gross Margin at -101.12. T2 Biosystems Inc.’s Net Margin is presently recorded at -707.93.
Additionally, TTOO Total Debt to Total Capital is recorded at 366.64, with Total Debt to Total Assets ending up at 164.14.
Reflecting on the efficiency of the workforce at the company, T2 Biosystems Inc. [TTOO] managed to generate an average of -$390,768 per employee. Receivables Turnover for the company is 3.62 with a Total Asset Turnover recorded at a value of 0.18.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.60 and a Current Ratio set at 5.00.
T2 Biosystems Inc. [TTOO]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, T2 Biosystems Inc. posted -0.29/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TTOO.
An analysis of insider ownership at T2 Biosystems Inc. [TTOO]
There are presently around $53 million, or 14.20% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 6,185,575, which is approximately 15.307% of the company’s market cap and around 0.10% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $10.81 million in TTOO stocks shares; and BLACKROCK INC., currently with $5.47 million in TTOO stock with ownership of nearly 0.023% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 38 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 4,477,688 shares. Additionally, 23 investors decreased positions by around 1,392,512 shares, while 16 investors held positions by with 15,436,289 shares. The mentioned changes placed institutional holdings at 21,306,489 shares, according to the latest SEC report filing. TTOO stock had 19 new institutional investments in for a total of 1,464,599 shares, while 11 institutional investors sold positions of 656,008 shares during the same period.